Skip to content

Adventris Pharmaceuticals

YC W23 · Active · Adventris makes cancer vaccines

Competitors

Adjacent

Also from W23

All of W23

About Adventris Pharmaceuticals

Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com

YC batch
W23 · Winter 2023
Status, per YC
Active
Category
Other
Team size
7
Location
Baltimore, MD, USA
Checked
35m ago

YC tags: Biotech, Healthcare, Therapeutics, Drug discovery, Oncology

Adventris Pharmaceuticals in W23: 274 companies, 68% AI

Adventris Pharmaceuticals: questions

Which YC batch was Adventris Pharmaceuticals in?

Adventris Pharmaceuticals was in Y Combinator's Winter 2023 batch (W23).

Is Adventris Pharmaceuticals still active?

Y Combinator lists Adventris Pharmaceuticals as active.

Where is Adventris Pharmaceuticals based?

Adventris Pharmaceuticals lists Baltimore, MD, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.